Getinge B stock reacts to UBS rating and AMF stake cut

Getinge B stock is in focus after a new UBS coverage with a neutral rating and a SEK 255 price target, while Swedish pension investor AMF reduces its stake, with the share moving modestly around SEK 245 on September 3, 2026.

Getinge B stock (ISIN SE0000202624) is trading close to SEK 245 on the Swedish market as of September 3, 2026, following renewed analyst attention and a partial exit by a major Swedish pension investor according to market data compiled by ad-hoc-news.de and trading indications reported via MarketScreener.

UBS initiates coverage with neutral view

According to a corporate news report on ad-hoc-news.de dated September 3, 2026, UBS has recently started coverage of Getinge B with a neutral rating and a price target of SEK 255 for the Swedish-listed shares.

The same report highlights that the UBS price target of SEK 255 is around 3.8 percent above the spot price of roughly SEK 245.60 quoted for Getinge B on September 3, 2026, a moderate upside that suggests a balanced view on valuation rather than a strong buy signal.

For investors, this quantified gap between target and current price is a concrete benchmark: with the stock at SEK 245.60 and the UBS target at SEK 255, the implied upside margin remains limited, encouraging a focus on execution and margins rather than pure multiple expansion.

AMF trims position while stock holds gains

The same ad-hoc-news.de coverage notes that institutional investor AMF Tjanstepension reduced its exposure to Getinge B on September 1, 2026, by selling part of its shareholding, which slightly changes the shareholder structure but left the share price relatively stable around the SEK 245 level.

Despite this partial stake reduction by AMF, Getinge B stock showed a daily gain of about 0.24 percent on September 3, 2026, according to market data referenced in the ad-hoc-news.de article, illustrating that the market digested the transaction without major volatility.

Year to date, the same source reports that Getinge B has achieved a performance of roughly 12.48 percent between January 1, 2026 and September 3, 2026, signalling that the stock has been able to generate double-digit returns in 2026 even as ownership shifts and analyst views remain moderate.

DACH trading reference and European index link

The ad-hoc-news.de coverage also references Tradegate as a key trading venue for Getinge B in the German market, where the share was quoted at EUR 22.13 with a daily gain of approximately 0.73 percent on September 3, 2026 according to data reported via MarketScreener, providing a concrete DACH anchor for investors using European secondary listings.

In the same context, the article notes that Getinge B is included as a component in the EN EUROPE 500 index compiled by Euronext, as shown on the Euronext EN EUROPE 500 index page, where Getinge B appears among the listed constituents with ISIN SE0000202624.

This index membership underscores Getinge B's role as a relevant European healthcare equipment name in broader pan-European equity benchmarks, which can influence passive fund flows and long-term demand from index-tracking strategies.

Medical technology portfolio and hospital solutions

Beyond the current market signals, Getinge B represents the listed series B shares of Getinge AB, a Swedish medical technology group that focuses on products and solutions for operating rooms, intensive care units, sterile processing and life science applications worldwide.

In the hospital environment, Getinge's offering spans surgical tables, anesthesia machines, ventilators, cardiac assist devices and patient monitoring systems, as well as sterilizers and washer-disinfectors that underpin infection control workflows.

The company also provides software for workflow management and traceability in sterilization departments, aiming to improve efficiency and patient safety by integrating hardware, consumables and digital services into cohesive hospital solutions.

Getinge B stock level and investor perspective

Based on the ad-hoc-news.de market summary, Getinge B stock closed around SEK 245.60 on the Swedish exchange on September 3, 2026, while the same coverage cites a Swedish closing level near SEK 245.00 for the previous session, indicating that the share is trading slightly above its most recent close and well above its level at the start of 2026.

With a year-to-date performance of about 12.48 percent in local currency and a UBS price target of SEK 255 that is only modestly above the current spot level, investors are likely to pay close attention to upcoming quarterly figures and any changes in guidance to judge whether the recent gains can be sustained.

Key data on Getinge B stock

• Company: Getinge AB
• ISIN: SE0000202624
• Ticker: GETI-B
• Trading venue: Stockholm exchange and Tradegate (secondary listing in EUR)
• Price (as of September 3, 2026): 245.60 SEK and 22.13 EUR
• Sector / Industry: Healthcare equipment and medical technology
• Index membership: EN EUROPE 500